approval · primary record
NALOXONE HYDROCHLORIDE
FDA · NDA · 2026-06-16
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-06-16 |
| Brand | REXTOVY |
| Sponsor | AMPHASTAR PHARMS INC |
| Route | NASAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:36.592Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:NALOXONE HYDROCHLORIDE:2026-06-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.